SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes

Condition:   Type 2 Diabetes Interventions:   Drug: Dapagliflozin;   Drug: Metformin Sponsors:   The George Institute;   The University of New South Wales;   Monash University;   University of Sydney Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials